Show simple item record

dc.contributor.authorEarl, Helenaen
dc.contributor.authorHiller, Louiseen
dc.contributor.authorHoward, Helen Cen
dc.contributor.authorDunn, Janet Aen
dc.contributor.authorYoung, Jennieen
dc.contributor.authorBowden, Sarah Jen
dc.contributor.authorMcDermaid, Michelleen
dc.contributor.authorWaterhouse, Anna Ken
dc.contributor.authorWilson, Gregoryen
dc.contributor.authorAgrawal, Rajiven
dc.contributor.authorO'Reilly, Susanen
dc.contributor.authorBowman, Angelaen
dc.contributor.authorRitchie, Diana Men
dc.contributor.authorGoodman, Andrewen
dc.contributor.authorHickish, Tamasen
dc.contributor.authorMcAdam, Karenen
dc.contributor.authorCameron, Daviden
dc.contributor.authorDodwell, Daviden
dc.contributor.authorRea, Daniel Wen
dc.contributor.authorCaldas, Carlosen
dc.contributor.authorProvenzano, Elenaen
dc.contributor.authorAbraham, Jeanen
dc.contributor.authorCanney, Peteren
dc.contributor.authorCrown, John Pen
dc.contributor.authorKennedy, M Johnen
dc.contributor.authorColeman, Roberten
dc.contributor.authorLeonard, Robert Cen
dc.contributor.authorCarmichael, James Aen
dc.contributor.authorWardley, Andrew Men
dc.contributor.authorPoole, Christopher Jen
dc.contributor.authortAnGo, trial collaboratorsen
dc.date.accessioned2017-05-22T10:50:36Z
dc.date.available2017-05-22T10:50:36Z
dc.date.issued2017-06en
dc.identifier.issn1470-2045
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/264339
dc.description.sponsorshipCancer Research UK core funding for Clinical Trials Unit at the University of Birmingham, Eli Lilly, Bristol-Myers Squibb, and Pfizer
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.language.isoenen
dc.publisherElsevier
dc.subjecttAnGo trial collaboratorsen
dc.subjectHumansen
dc.subjectBreast Neoplasmsen
dc.subjectLymphatic Metastasisen
dc.subjectPaclitaxelen
dc.subjectCyclophosphamideen
dc.subjectEpirubicinen
dc.subjectReceptor, erbB-2en
dc.subjectReceptors, Estrogenen
dc.subjectReceptors, Progesteroneen
dc.subjectDeoxycytidineen
dc.subjectAntineoplastic Combined Chemotherapy Protocolsen
dc.subjectDisease-Free Survivalen
dc.subjectChemotherapy, Adjuvanten
dc.subjectRadiotherapyen
dc.subjectMastectomy, Segmentalen
dc.subjectSurvival Rateen
dc.subjectFollow-Up Studiesen
dc.subjectMiddle Ageden
dc.subjectFemaleen
dc.subjectIntention to Treat Analysisen
dc.titleAddition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.en
dc.typeArticle
prism.endingPage769
prism.publicationDate2017en
prism.publicationNameThe Lancet. Oncologyen
prism.startingPage755
prism.volume18en
dc.identifier.doi10.17863/CAM.9805
dcterms.dateAccepted2017-03-01en
rioxxterms.versionofrecord10.1016/s1470-2045(17)30319-4en
rioxxterms.versionAMen
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2017-06en
dc.contributor.orcidEarl, Helena [0000-0003-1549-8094]
dc.contributor.orcidCaldas, Carlos [0000-0003-3547-1489]
dc.contributor.orcidAbraham, Jean [0000-0003-0688-4807]
dc.identifier.eissn1474-5488
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idCancer Research UK (A6783)
pubs.funder-project-idCancer Research UK (A24622)
pubs.funder-project-idAcademy of Medical Sciences (ALI 01/08/14)
pubs.funder-project-idMEDICAL RESEARCH COUNCIL (MR/M008975/1)
pubs.funder-project-idAcademy of Medical Sciences (unknown)
pubs.funder-project-idCancer Research UK (16465)
pubs.funder-project-idCambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
pubs.funder-project-idEuropean Commission FP7 Network of Excellence (NoE) (260791)
pubs.funder-project-idCancer Research UK (A15580)
pubs.funder-project-idCambridge University Hospitals NHS Foundation Trust (CUH) (RG51913)
pubs.funder-project-idEC FP7 NOE (260791)
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (unknown)
pubs.funder-project-idECH2020 EUROPEAN RESEARCH COUNCIL (ERC) (694620)
pubs.funder-project-idEC FP7 CP (242006)
pubs.funder-project-idEuropean Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA) FP7 Innovative Medicines Initiative (IMI) (115749)
pubs.funder-project-idMRC (MR/P012442/1)
pubs.funder-project-idCancer Research UK (20544)
pubs.funder-project-idEC FP7 CP (258967)
pubs.funder-project-idCancer Research UK (C507/A16278)
pubs.funder-project-idEuropean Commission FP7 Collaborative projects (CP) (258967)
pubs.funder-project-idPathological Society of Great Britain & Ireland (CDF 2012/01)
pubs.funder-project-idCancer Research UK (unknown)
pubs.funder-project-idCancer Research UK (60098573)
pubs.funder-project-idCancer Research UK (unknown)
pubs.funder-project-idCancer Research UK (CB4140)
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (NF-SI-0515-10090)
rioxxterms.freetoread.startdate2017-11-04


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record